SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors digest a massive revenue beat alongside high-profile contract wins, with the community actively debating whether the stock's recent volatility is a short-term reaction to broader market pressure or a long-term entry opportunity. Discussion is focused on the tension between robust AI infrastructure demand and concerns over debt levels, with many traders looking toward upcoming earnings calls for further clarity on hyperscaler partnerships.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to intense community speculation regarding potential platform growth, executive news, and heavy partisan debate surrounding Donald Trump's political narrative. Investors and community members are actively discussing the stock's volatility, potential catalysts like upcoming merger filings, and a highly polarized discourse over the company's valuation versus its revenue.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing significant market volatility after FDA briefing documents challenged the statistical methods and efficacy of its DMD therapy, Deramiocel. While the company is actively pushing back by citing the use of obsolete analysis plans by the FDA, investors remain sharply divided as they await the outcome of the upcoming advisory committee meeting.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as investors weigh an ongoing patent infringement lawsuit against the company's strategic pivot toward AI infrastructure and power semiconductors. Community sentiment is deeply divided, with many traders focused on the stock's recent volatility and the potential impact of future guidance on its long-term growth prospects.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is surging following a massive earnings beat and an upgraded FY27 outlook, with the company forecasting accelerated revenue growth that significantly exceeds analyst expectations. The community is buzzing over the stock's impressive operating margin expansion and its strategic role in the AI infrastructure supply chain, fueling debates among investors over whether to lock in gains after the recent rally or continue holding to capture long-term growth as hyperscalers maintain high capital expenditure levels.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as investors weigh a strong quarterly performance and improved margins against a cautious third-quarter revenue outlook. While the community remains divided over the short-term price action, there is significant ongoing discussion regarding the stock's long-term potential as a critical player in the advanced semiconductor packaging and AI supply chain.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to a significant $1.5 million NSF grant for fault-tolerant computing and a strategic pivot toward commercial enterprise partnerships like the expanded AT&T agreement. Community discussion remains polarized, with bulls highlighting the stock's potential as a sector leader following its Nasdaq transition, while bears caution against high valuation multiples and the volatility common in high-beta speculative tech.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is currently in the spotlight as investors debate the impact of the company's aggressive share buyback program and its ongoing treasury strategy focused on Ethereum accumulation. While some in the community see the recent buybacks as a key catalyst for potential price recovery and a way to counter share dilution, others remain skeptical, pointing to the persistent discount between the stock's market value and its underlying crypto holdings as a sign of management's poor execution.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.

MapLight Therapeutics Inc.

MapLight Therapeutics is seeing intense volatility following mixed topline results from its Phase 2 ZEPHYR trial, with community sentiment deeply divided between bargain hunters seeking a rebound and critics questioning the clinical data. While some traders are focused on the company's cash position and potential for a 'snap back,' others are wary of the sharp share price decline and are debating whether the recent dip represents an overreaction or a long-term valuation shift.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is facing heightened volatility and selling pressure as investors scrutinize the company's role in a multibillion-dollar financing deal for OpenAI, fueling concerns over counterparty risk and potentially circular financing structures. The community is deeply divided between long-term bulls who view the dip as an opportunity to accumulate shares at a discount and skeptical bears who are focusing on rising credit risks, sector-wide rotation, and intensifying semiconductor competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch

 UNH's post-earnings pullback follows a 52-week high, as stronger guidance offsets Medicaid pressures and spotlights healthcare ETFs with sizable exposure.

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch

Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.

The Zacks Analyst Blog Highlights SPY, DIA, QQQ, WCLD, XTL, RSPC, IHF and XOP

Several sector ETFs, including WCLD, XTL and XOP, are holding steady and even gaining despite market volatility tied to Middle East tensions.

5 Sector ETFs Held Steady Amid Iran Conflicts 

Iran tensions rattle markets, but select sector ETFs stay resilient. Here are 5 funds gaining momentum amid volatility.

Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results

Healthcare ETFs draw attention as UNH climbs 4% on mixed Q4 results, a better 2026 cost outlook, and rising concerns over Medicaid pressure.

UNH Stock Slides Pre-Market: United Health Warns Of Softer FY26 As Medicare Pressures Mount 

Equity

UnitedHealth expects revenue in 2026 of around $439 billion, a 2% year-over-year decline.

Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan

Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.

iShares Trust - iShares U.S. Healthcare Providers ETF

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

The Fed's July 28-29 meeting has markets debating a hold versus a hike, not a cut, with CME FedWatch pricing roughly a 65% chance of no change and rising odds of a September rate increase amid inflation running well above the 2% target. What do you expect the Fed to decide? Drop a comment with when you expect the first cut/hike to be.

What do you expect the Fed to decide at its FOMC meeting?  
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

IHFiShares U.S. Healthcare Providers ETF

Latest IHF News